Lantern Pharma Announces Upcoming Conference Presentations


Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform to transform the pace, risk and cost of oncology drug discovery and development, and identify patients who will benefit from its targeted oncology drug candidates, announced that Panna Sharma, CEO and President, will participate in the following investor events in December:

  1. Diamond Equity Research Emerging Growth Invitational
    Date/time: December 1, 2020 at 12:20 pm ET
    Zoom Link for Live Event:

  2. hubXchange Virtual US East Coast AI in Drug Discovery Xchange
    Date/time: December 2, 2020 at 12:20 pm ET

  3. 2020 Benzinga Global Small Cap Conference
    Date/time: December 9, 2020 at 3:30 p.m. ET
    Zoom Link for Live Event:

All meetings and presentations will be held virtually. Investors and media interested in meeting with Panna Sharma should contact Marek Ciszewski, J.D., at: [email protected] or +1.628.777.3167. Registered conference attendees may also request meetings through the respective conference registration system.

Get involved!

Get Connected!
Connect with like-minded people, start groups, share files and documents, create group video meetings, attend conferences, and more.


No comments yet